ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

NAHID VANDSHEKARI M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,684Medicare Part D Prescriptions Filled, Including Refills

Rank: 159 out of 4623

$809 Total Retail Price of All Prescriptions

Rank: 4622 out of 4623

595 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
100% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 595 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 595 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,709 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
WARFARIN SODIUM 469 402 1 24
OYSTER SHELL CALCIUM W-VIT D 436 418 10 2 261
ASPIRIN EC 381 368 3 228
LEVOTHYROXINE SODIUM 371 331 4 1
OMEPRAZOLE 351 334 5 7
MULTIVITAMINS 345 337 10 6 259
ENALAPRIL MALEATE 322 319 7 41
MAPAP 308 283 8 256
NAMENDA 272 272 9 36
SIMVASTATIN 262 254 10 2
LISINOPRIL 244 228 11 4
FUROSEMIDE 236 218 12 8
ALENDRONATE SODIUM 228 227 13 22
LORATADINE 223 203 14 327
DONEPEZIL HCL 219 216 15 30
SERTRALINE HCL 213 210 16 26
HYDROCODONE-ACETAMINOPHEN 197 189 S3 17 3
SENNA 194 187 18 299
MULTILEX-T-M WITH MINERALS 192 179 10 19 274
VITAMIN A & D 191 164 10 20 355
PANTOPRAZOLE SODIUM 180 180 21 35
METOPROLOL TARTRATE 178 170 22 9
LOVASTATIN 177 172 23 34
LACTULOSE 175 174 24 106
OMEGA-3 169 158 10 25 330
AMLODIPINE BESYLATE 166 161 26 5
MIRTAZAPINE 153 153 27 57
CLOPIDOGREL 153 138 27 31
DOK 152 134 29 305
QUETIAPINE FUMARATE 147 147 30 74
ASPIRIN 143 132 31 325
METFORMIN HCL 143 133 31 6
FERROUS SULFATE 138 131 33 319
HYDROCHLOROTHIAZIDE 136 130 34 10
LOSARTAN POTASSIUM 129 111 35 21
TAMSULOSIN HCL 125 125 36 29
CEFUROXIME 124 119 37 152
TRAZODONE HCL 123 122 38 42
CALCIUM WITH VITAMIN D 123 123 38 268
EXELON 121 121 40 107
ESCITALOPRAM OXALATE 119 117 41 75
TRAMADOL HCL 118 91 42 15
RANITIDINE HCL 116 113 43 47
GABAPENTIN 109 101 44 16
METOPROLOL SUCCINATE 105 94 45 13
REFRESH CELLUVISC 100 98 10 46 436
KLOR-CON 10 97 97 47 187
DOC-Q-LACE 94 87 48 394
MUSCLE RUB 91 82 10 49 483
PLAVIX 90 86 50 45
DIGOXIN 86 83 51 58
VITAMIN B-12 80 73 52 409
CARVEDILOL 80 78 52 25
VITAMIN D2 76 66 54 304
RISPERIDONE 76 74 54 72
METAMUCIL 73 65 10 56 338
MELOXICAM 72 71 57 27
LANTUS 72 57 57 44
PREDNISONE 67 49 59 50
TRIPLE ANTIBIOTIC 67 67 10 59 467
CALMOSEPTINE 67 67 59 391
POLYETHYLENE GLYCOL 3350 66 63 62 91
FELODIPINE ER 62 62 63 174
IPRATROPIUM BROMIDE 61 60 64 216
CITALOPRAM HBR 60 58 65 23
GLYBURIDE 60 60 R 65 59
PATADAY 59 54 67 300
ZINC OXIDE 58 56 10 68 458
KLOR-CON M20 56 49 69 102
DIABETIC TUSSIN DM 55 52 10 70 413
GLIPIZIDE 54 54 71 49
ARTIFICIAL TEARS 53 52 72 402
LEXAPRO 52 51 73 220
SPIRONOLACTONE 51 48 74 77
FENOFIBRATE 51 42 74 54
ZOLPIDEM TARTRATE 51 43 74 18
SINGULAIR 50 50 77 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.